Amino Innovations Expands Market Presence Alongside Global Health Leaders Gary Brecka, Lara Trump, and Tito Ortiz at Leading Biohacking and Longevity Summits
(TheNewswire)
Vancouver, British Columbia– October 10, 2025 – TheNewswire - PangeaNatural Foods Inc. (CSE: PNGA) (OTC: PNGAF)(“ Pangea ” or the “ Company ”), is pleased to announce that itswholly owned subsidiary, Amino Innovations, is expanding its marketpresence through sponsorships and featured exhibitions at threehigh-profile health and longevity events this October.
MoreLife Biohacking Summit, October11-12, 2025 | Fort Lauderdale, Florida
Amino Innovations is proud to sponsor andexhibit at the MoreLife Biohacking Summit, one of the fastest growingconferences in the global longevity movement. This year’s summitfeatures keynote speakers GaryBrecka , renowned human biologist and founder ofThe Ultimate Human; LaraTrump , wellness advocate and former Co-Chair orthe Republican National Committee; and Tito Ortiz , UFC Hallof Famer and early biohacker. The event brings together entrepreneurs,athletes, and wellness professionals focused on health optimizationand human performance.
The Healthspan Summit, October 3-5,2025 | Los Angeles, California
Earlier this month, Amino Innovations sponsored andexhibited at the Healthspan Summit, a leading forum for cellularmedicine and regenerative health innovation. The event featurednotable speakers including Dr.William Seeds , a pioneer in peptide and cellularrepair science; DavidPerez , a leader in regenerative and functionalmedicine; and Dr. StephanieVenn-Watson , physician-scientist and longevityexpert. Participation at the Healthspan Summit provided an opportunityto connect with leading clinicians, wellness entrepreneurs, andinvestors focused on advancing peptide science and next-generationtherapeutic delivery systems.
Both summits provided Amino Innovations with a platformto actively showcase its non-injectable peptide products to an engagedaudience of health professionals and performance enthusiasts. Livedemonstrations and in-person discussions allowed attendees toexperience the convenience and efficacy of Amino’s delivery formatsfirsthand, sparking strong interest from clinic operators, athletes,and wellness influencers. The company’s presence across these twoevents positioned Amino as an emerging innovator and reinforced itsmission to make “Peptides, Reimagined” a reality within the globalmarket.
Disrupt Business 2025, October 17-19,2025 | Orlando, California
Amino Innovations is also excited to announce thatCo-Founder and Chief Science Officer Justin Kirkland will be afeatured speaker at Disrupt Business 2025, a leading conference forhealth practitioners and wellness entrepreneurs. His session willexplore needle-free peptide delivery systems and bioavailableformulations, offering a preview of Amino Innovations upcoming peptidepatch launch and its potential to redefine convenient, at-home peptidetherapy.
About PangeaNatural Foods Inc.
Pangea Natural Foods Inc. is a North Americanmanufacturer specializing in clean-label foods and innovative wellnessproducts. Through its subsidiary Amino Innovations, the Company offersadvanced, needle-free peptide therapies that support recovery,cognitive function, and overall health.
On Behalf of the Board ofDirectors
"PratapSandhu"
Pratap Sandhu
CEO, Corporate Secretary and Director
+1 (604) 765-8069
Forward-Looking Information
This news release containsforward–looking statements and forward–looking information withinthe meaning of applicable securities laws. These statements relate tofuture events or future performance. All statements other thanstatements of historical fact may be forward–looking statements orinformation. The forward–looking statements and information arebased on certain key expectations and assumptions made by themanagement of the Company. As a result, there can be no assurance thatthe acquisition or related matters will be completed as proposed or atall. Although management of the Company believes that the expectationsand assumptions on which such forward-looking statements andinformation are based are reasonable, undue reliance should not beplaced on the forward–looking statements and information since noassurance can be given that they will prove to be correct.
Forward-looking statements andinformation are provided for the purpose of providing informationabout the current expectations and plans of management of the Companyrelating to the future. Readers are cautioned that reliance on suchstatements and information may not be appropriate for other purposes,such as making investment decisions. Since forward–lookingstatements and information address future events and conditions, bytheir very nature they involve inherent risks and uncertainties.Actual results could differ materially from those currentlyanticipated due to a number of factors and risks. These include, butare not limited to, the ability of the Company to complete its plannedfuture activities and anticipated business plans. Other factors mayalso adversely affect the future results or performance of theCompany, including general economic, market or business conditions,changes in the financial markets and changes in laws, regulations andpolicies affecting the Company's operations and theCompany's limited operating history. Accordingly, readers shouldnot place undue reliance on the forward–looking statements andinformation contained in this news release. Readers are cautioned thatthe foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release aremade as of the date hereof and no undertaking is given to updatepublicly or revise any forward–looking statements or information,whether as a result of new information, future events or otherwise,unless so required by applicable securities laws. The forward-lookingstatements or information contained in this news release are expresslyqualified by this cautionary statement.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: PNGAF
PNGAF Trading
7.41% G/L:
$0.2913 Last:
250 Volume:
$0.2913 Open:



